Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Renal

Renal (19 companies · 14 conditions)

Conditions

Lupus Nephritis 9 Rare Immunoglobulin A Nephropathy 6 Rare Focal Segmental Glomerulosclerosis 4 Rare Membranous Nephropathy 4 Rare Chronic Kidney Disease 2 Hyperphosphatemia 2 Minimal Change Disease 2 Rare Acute Kidney Injury 1 Alport Syndrome 1 Rare Atypical Hemolytic Uremic Syndrome 1 Rare C3 Glomerulopathy 1 Rare Cystinuria 1 Rare Diabetes Insipidus 1 Rare Polycystic Kidney Disease 1 Rare

Companies

Ticker Company Therapeutic areas In Renal Lead stage Programs
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 7 Approved 10
ANNX Annexon HematologyNeurology+2 Rare 1 NDA Submitted 6
ARDX Ardelyx Renal 1 Approved 4
ARTV Artiva Biotherapeutics DermatologyImmunology+2 Rare 1 Phase 2 16
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved 12
CABA Cabaletta Bio DermatologyImmunology+2 Rare 1 Phase 1 8
IPSC Century Therapeutics ImmunologyMetabolic+1 Rare 2 Phase 1 11
CLYM Climb Bio HematologyImmunology+1 Rare 3 Phase 2 7
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 1 NDA Submitted 10
ELOX Eloxx Pharmaceuticals Renal Rare 2 Phase 2 4
ETON Eton Pharmaceuticals GI/HepatologyMetabolic+1 Rare 1 Approved 14
JBIO Jade Biosciences ImmunologyRenal Rare 1 Phase 2 6
KYTX Kyverna Therapeutics ImmunologyNeurology+1 Rare 1 NDA Submitted 7
NKTX Nkarta ImmunologyNeurology+1 Rare 2 Phase 1 7
PCSA Processa Pharmaceuticals GI/HepatologyOncology+1 Rare 2 Phase 2 7
TVTX Travere Therapeutics MetabolicRenal Rare 6 Approved 7
UNCY Unicycive Therapeutics Renal 1 NDA Submitted 2
VERA Vera Therapeutics Infectious DiseaseRenal Rare 5 Approved 8
XNCR Xencor HematologyImmunology+4 Rare 1 Approved 30